Corticothalamic network dysfunction and Alzheimer's disease

被引:14
|
作者
Jagirdar, Rohan [1 ]
Chin, Jeannie [1 ]
机构
[1] Baylor Coll Med, Dept Neurosci, Memory & Brain Res Ctr, One Baylor Plaza,Rm S707, Houston, TX 77030 USA
关键词
Thalamic reticular nucleus; Sleep maintenance; Seizures; Hippocampus; Thalamus; Attention; THALAMIC RETICULAR NUCLEUS; MILD COGNITIVE IMPAIRMENT; SLOW-WAVE ACTIVITY; NONCHOLINERGIC NEURONS; SYNAPTIC-INTERACTIONS; ATTENTION-DEFICIT; SLEEP DISTURBANCE; SEIZURES; DEMENTIA; MEMORY;
D O I
10.1016/j.brainres.2017.09.014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is a devastating neurodegenerative disease that is characterized by progressive cognitive decline and a prominent loss of hippocampal-dependent memory. Therefore, much focus has been placed on understanding the function and dysfunction of the hippocampus in AD. However, AD is also accompanied by a number of other debilitating cognitive and behavioral alterations including deficits in attention, cognitive processing, and sleep maintenance. The underlying mechanisms that give rise to impairments in such diverse behavioral domains are unknown, and identifying them would shed insight into the multifactorial nature of AD as well as reveal potential new therapeutic targets to improve overall function in AD. We present here several lines of evidence that suggest that dysregulation of the corticothalamic network may be a common denominator that contributes to the diverse cognitive and behavioral alterations in AD. First, we will review the mechanisms by which this network regulates processes that include attention, cognitive processing, learning and memory, and sleep maintenance. Then we will review how these behavioral and cognitive domains are altered in AD. We will also discuss how dysregulation of tightly regulated activity in the corticothalamic network can give rise to non convulsive seizures and other forms of epileptiform activity that have also been documented in both AD patients and transgenic mouse models of AD. In summary, the corticothalamic network has the potential to be a master regulator of diverse cognitive and behavioral domains that are affected in AD. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:38 / 45
页数:8
相关论文
共 50 条
  • [31] Mitochondrial dysfunction and Alzheimer's disease
    Ghosh, SS
    Miller, S
    Herrnstadt, C
    Fahy, E
    Shinobu, LA
    Galasko, D
    Thal, LJ
    Beal, MF
    Howell, N
    Parker, WD
    Davis, RE
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 59 - 66
  • [32] Executive dysfunction in Alzheimer's disease
    Collette, F
    Van der Linden, M
    Salmon, E
    CORTEX, 1999, 35 (01) : 57 - 72
  • [33] Vestibular dysfunction and Alzheimer's disease
    Smith, Paul F.
    MEDICAL HYPOTHESES, 2013, 81 (06) : 1169 - 1170
  • [34] Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
    Ramsey Najm
    Emily A. Jones
    Yadong Huang
    Molecular Neurodegeneration, 14
  • [35] Pericyte dysfunction in Alzheimer's disease
    Miners, S.
    Harris, R.
    Love, S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2018, 44 : 12 - 13
  • [36] Olfactory dysfunction in Alzheimer's disease
    Zou, Yong-ming
    Lu, Da
    Liu, Li-ping
    Zhang, Hui-hong
    Zhou, Yu-ying
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 869 - 875
  • [37] Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease
    Najm, Ramsey
    Jones, Emily A.
    Huang, Yadong
    MOLECULAR NEURODEGENERATION, 2019, 14 (1)
  • [38] Discovering Brain Network Dysfunction in Alzheimer's Disease Using Brain Hypergraph Neural Network
    Cai, Hongmin
    Zhou, Zhixuan
    Yang, Defu
    Wu, Guorong
    Chen, Jiazhou
    MEDICAL IMAGE COMPUTING AND COMPUTER ASSISTED INTERVENTION, MICCAI 2023, PT V, 2023, 14224 : 230 - 240
  • [39] Lysosomal dysfunction in Alzheimer's disease and Parkinson disease
    Connolly, Owen M.
    Wahdan, Malak
    Deivasigamani, Senthilkumar
    Modi, Souvik
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 28 - 28
  • [40] Central autonomic network dysfunction and plasma Alzheimer's disease biomarkers in older adults
    Lohman, Trevor
    Kapoor, Arunima
    Engstrom, Allison C.
    Shenasa, Fatemah
    Alitin, John Paul M.
    Gaubert, Aimee
    Rodgers, Kathleen E.
    Bradford, David
    Mather, Mara
    Han, S. Duke
    Head, Elizabeth
    Sordo, Lorena
    Thayer, Julian F.
    Nation, Daniel A.
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)